Treatment of cereal flour and semolina for consumption by celiac patients

US9730458B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9730458-B2
Application numberUS-31224007-A
CountryUS
Kind codeB2
Filing dateOct 29, 2007
Priority dateOct 30, 2006
Publication dateAug 15, 2017
Grant dateAug 15, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the use of an enzymatic method for treating flour, semolina and protein extracts derived from cereals known to stimulate a pathological immune response in patients affected by Celiac Disease (CD). Said treatment drastically reduces or completely eliminates the toxicity of gluten or similar products derived from other cereals. The method uses the catalytic activity of microbial transglutaminase and, in particular, its ability to bind proteins in cereal flour or semolina to an alkylated (C 1 -C 4 ) derivative of lysine. After the treatment said proteins extracted from flour show a substantially lowered immuno-stimulatory activity in celiac patients T lymphocytes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for obtaining cereal products suitable for gluten-sensitive individuals, the process comprising the steps of: a. providing a cereal product comprising gliadin and gluten, both the gliadin and the gluten having glutamine residues; b. treating the glutamine residues of the gliadin and the gluten with a C 1 -C 4 alkyl ester of lysine in the presence of a transglutaminase, said transglutaminase being an amine γ-glutamyl-transferase EC 2.3.2.13. 2. The method according to claim 1 wherein said transglutaminase is tissue or microbial transglutaminase. 3. The method according to claim 2 wherein said transglutaminase is extractive or is recombinant transglutaminase. 4. The method according to claim 2 wherein said transglutaminase is food-grade. 5. The method according to claim 2 wherein said transglutaminase is microbial transglutaminase. 6. The method according to claim 1 wherein said cereal products comprises gluten and/or gliadin. 7. The method according to claim 1 wherein said cereal product is selected from the group consisting of: oats, wheat, barley or rye. 8. The method according to claim 7 wherein the product is in the form of flour or semolina. 9. The method according to claim 1 wherein said cereal product is selected from the group consisting of: gliadin, avenin, hordein or secalin. 10. The method according to claim 9 wherein said product comprises grain starch. 11. The method according to claim 7 further comprising a step of preparation of a food product. 12. The method of claim 11 wherein said food product is suitable for gluten-sensitive individuals. 13. The method according to claim 1 wherein said alkyl ester is a methyl ester of lysine.

Assignees

Inventors

Classifications

  • from cereals, flour, bran · CPC title

  • of vegetable proteins · CPC title

  • Other treatment of flour or dough before baking, e.g. cooling, irradiating or heating (preservation of flour or dough before baking A23B40/00) · CPC title

  • A21D2/268Primary

    Hydrolysates from proteins (hydrolysis of proteins A23J3/30) · CPC title

  • Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9730458B2 cover?
The present invention relates to the use of an enzymatic method for treating flour, semolina and protein extracts derived from cereals known to stimulate a pathological immune response in patients affected by Celiac Disease (CD). Said treatment drastically reduces or completely eliminates the toxicity of gluten or similar products derived from other cereals. The method uses the catalytic activi…
Who is the assignee on this patent?
Rossi Mauro, Gianfrani Carmela, Siciliano Rosa Anna, and 1 more
What technology area does this patent fall under?
Primary CPC classification A21D2/268. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).